Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries

Simple item page
dc.contributor.authorStolbrink M.
dc.contributor.authorChinouya M.J.
dc.contributor.authorJayasooriya S.
dc.contributor.authorNightingale R.
dc.contributor.authorEvans-Hill L.
dc.contributor.authorAllan K.
dc.contributor.authorAllen H.
dc.contributor.authorBalen J.
dc.contributor.authorBeacon T.
dc.contributor.authorBissell K.
dc.contributor.authorChakaya J.
dc.contributor.authorChiang C-Y.
dc.contributor.authorCohen M.
dc.contributor.authorDevereux G.
dc.contributor.authorEl Sony A.
dc.contributor.authorHalpin D.M.G.
dc.contributor.authorHurst J.R.
dc.contributor.authorKiprop C.
dc.contributor.authorLawson A.
dc.contributor.authorMacé C.
dc.contributor.authorMakhanu A.
dc.contributor.authorMakokha P.
dc.contributor.authorMasekela R.
dc.contributor.authorMeme H.
dc.contributor.authorKhoo E.M.
dc.contributor.authorNantanda R.
dc.contributor.authorPasternak S.
dc.contributor.authorPerrin C.
dc.contributor.authorReddel H.
dc.contributor.authorRylance S.
dc.contributor.authorSchweikert P.
dc.contributor.authorWere C.
dc.contributor.authorWilliams S.
dc.contributor.authorWinders T.
dc.contributor.authorYorgancioglu A.
dc.contributor.authorMarks G.B.
dc.contributor.authorMortimer K.
dc.date.accessioned2024-07-22T08:03:57Z
dc.date.available2024-07-22T08:03:57Z
dc.date.issued2022
dc.description.abstractBACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low- and middle-income countries (LMICs), causing avoidable morbidity and mortality. The International Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this topic in February 2022. METHODS : Focused group discussions were informed by literature and presentations summarising experiences of obtaining inhaled medicines in LMICs. The virtual meeting was moderated using a topic guide around barriers and solutions to improve access. The thematic framework approach was used for analysis. RESULT S : A total of 58 key stakeholders, including patients, healthcare practitioners, members of national and international organisations, industry and WHO representatives attended the meeting. There were 20 pre-meeting material submissions. The main barriers identified were 1) low awareness of CRDs; 2) limited data on CRD burden and treatments in LMICs; 3) ineffective procurement and distribution networks; and 4) poor communication of the needs of people with CRDs. Solutions discussed were 1) generation of data to inform policy and practice; 2) capacity building; 3) improved procurement mechanisms; 4) strengthened advocacy practices; and 5) a World Health Assembly Resolution. CONC L U S ION: There are opportunities to achieve improved access to affordable, quality-assured inhaled medicines in LMICs through coordinated, multi-stakeholder, collaborative efforts. © 2022 International Union against Tubercul. and Lung Dis.. All rights reserved.
dc.identifier.DOI-ID10.5588/ijtld.22.0270
dc.identifier.issn10273719
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12503
dc.language.isoEnglish
dc.publisherInternational Union Against Tuberculosis and Lung Disease
dc.rightsAll Open Access; Hybrid Gold Open Access
dc.subjectDeveloping Countries
dc.subjectGlobal Health
dc.subjectHumans
dc.subjectIncome
dc.subjectPoverty
dc.subjectRespiration Disorders
dc.subjectArticle
dc.subjectawareness
dc.subjectcapacity building
dc.subjectchronic obstructive lung disease
dc.subjectchronic respiratory tract disease
dc.subjectcost benefit analysis
dc.subjectdisease burden
dc.subjectdrug quality
dc.subjectforced expiratory volume
dc.subjecthealth care access
dc.subjecthealth care cost
dc.subjecthealth care personnel
dc.subjecthealth insurance
dc.subjecthuman
dc.subjectlow income country
dc.subjectmiddle income country
dc.subjectmorbidity
dc.subjectpharmacist
dc.subjectpharmacy (shop)
dc.subjectqualitative research
dc.subjectstakeholder engagement
dc.subjectbreathing disorder
dc.subjectdeveloping country
dc.subjectglobal health
dc.subjectincome
dc.subjectpoverty
dc.titleImproving access to affordable quality-assured inhaled medicines in low- and middle-income countries
dc.typeArticle

Files

Collections

Scopus Koleksiyonu